Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 427, 474 (5 February 2004) | doi:10.1038/427474a
Drug suicide risks prompt call for FDA action
Erika Check
A scientific advisory panel has joined a chorus of patient groups and consumer advocates this week in calling for the US Food and Drug Administration (FDA) to curb the use of certain antidepressant medications in young people."We would like the FDA to go ahead and issue a stronger warning to clinicians regarding the possible risks of these medicines," says psychiatrist Matthew Rudorfer of the National Institute of Mental Health in Bethesda, Maryland.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.